These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 33439866)

  • 1. Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study.
    Wallentin L; Eriksson N; Olszowka M; Grammer TB; Hagström E; Held C; Kleber ME; Koenig W; März W; Stewart RAH; White HD; Åberg M; Siegbahn A
    PLoS Med; 2021 Jan; 18(1):e1003513. PubMed ID: 33439866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.
    Hagström E; Held C; Stewart RA; Aylward PE; Budaj A; Cannon CP; Koenig W; Krug-Gourley S; Mohler ER; Steg PG; Tarka E; Östlund O; White HD; Siegbahn A; Wallentin L;
    Clin Chem; 2017 Jan; 63(1):325-333. PubMed ID: 27811204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease.
    Lindholm D; Lindbäck J; Armstrong PW; Budaj A; Cannon CP; Granger CB; Hagström E; Held C; Koenig W; Östlund O; Stewart RAH; Soffer J; White HD; de Winter RJ; Steg PG; Siegbahn A; Kleber ME; Dressel A; Grammer TB; März W; Wallentin L
    J Am Coll Cardiol; 2017 Aug; 70(7):813-826. PubMed ID: 28797349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
    Pol T; Hijazi Z; Lindbäck J; Oldgren J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Granger CB; Lopes RD; Yusuf S; Siegbahn A; Wallentin L
    Cardiovasc Res; 2022 Jul; 118(9):2112-2123. PubMed ID: 34358298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
    Held C; White HD; Stewart RAH; Budaj A; Cannon CP; Hochman JS; Koenig W; Siegbahn A; Steg PG; Soffer J; Weaver WD; Östlund O; Wallentin L;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.
    Bergmark BA; Udell JA; Morrow DA; Cannon CP; Steen DL; Jarolim P; Budaj A; Hamm C; Guo J; Im K; Kuder JF; Braunwald E; Sabatine MS; O'Donoghue ML
    JAMA Cardiol; 2018 Jun; 3(6):473-480. PubMed ID: 29710336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
    Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy.
    Hilvo M; Wallentin L; Ghukasyan Lakic T; Held C; Kauhanen D; Jylhä A; Lindbäck J; Siegbahn A; Granger CB; Koenig W; Stewart RAH; White H; Laaksonen R;
    J Am Heart Assoc; 2020 May; 9(10):e015258. PubMed ID: 32375553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.
    Fluschnik N; Ojeda F; Zeller T; Jørgensen T; Kuulasmaa K; Becher PM; Sinning C; Blankenberg S; Westermann D
    PLoS One; 2018; 13(5):e0197497. PubMed ID: 29771963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome.
    Correa S; Morrow DA; Braunwald E; Davies RY; Goodrich EL; Murphy SA; Cannon CP; O'Donoghue ML
    J Am Heart Assoc; 2018 Oct; 7(20):e009077. PubMed ID: 30371283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.
    McEvoy JW; Chen Y; Ndumele CE; Solomon SD; Nambi V; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
    JAMA Cardiol; 2016 Aug; 1(5):519-28. PubMed ID: 27439107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
    Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
    JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease.
    Vedin O; Hagström E; Östlund O; Avezum A; Budaj A; Flather MD; Harrington RA; Koenig W; Soffer J; Siegbahn A; Steg PG; Stewart RAH; Wallentin L; White HD; Held C;
    Int J Cardiol; 2017 Oct; 245():271-276. PubMed ID: 28735759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy.
    Held C; Hadziosmanovic N; Aylward PE; Hagström E; Hochman JS; Stewart RAH; White HD; Wallentin L
    J Am Heart Assoc; 2022 Feb; 11(3):e023667. PubMed ID: 35060389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
    Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
    Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease: Results of the KAROLA Study.
    Jansen H; Koenig W; Jaensch A; Mons U; Breitling LP; Scharnagl H; Stojakovic T; Schunkert H; Brenner H; Rothenbacher D
    Clin Chem; 2016 Oct; 62(10):1372-9. PubMed ID: 27540030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study.
    Hagström E; James SK; Bertilsson M; Becker RC; Himmelmann A; Husted S; Katus HA; Steg PG; Storey RF; Siegbahn A; Wallentin L;
    Eur Heart J; 2016 Apr; 37(16):1325-33. PubMed ID: 26417057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease.
    Feldreich T; Nowak C; Fall T; Carlsson AC; Carrero JJ; Ripsweden J; Qureshi AR; Heimbürger O; Barany P; Stenvinkel P; Vuilleumier N; Kalra PA; Green D; Ärnlöv J
    J Nephrol; 2019 Feb; 32(1):111-119. PubMed ID: 30499038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.